• BlackRock kept its total voting rights stake in Fresenius Medical Care unchanged at 7.04% as of June 16.
• Voting rights attached to shares edged up to 5.02% from 4.97%.
• Voting rights through instruments slipped to 2.02% from 2.07%, including lent securities and contracts for difference.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC - Fresenius Medical Care AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2350222_en) on June 19, 2026, and is solely responsible for the information contained therein.